Transplantation for retinal diseases
视网膜疾病移植
基本信息
- 批准号:14370553
- 负责人:
- 金额:$ 8.58万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We report a subretinal iris pigment epithelial cell (IPE) transplantation with safely. When these cells were genetically engineered that expressing neurotrophic factors, the transplantation rescued the photoreceptor cells from phototoxicity. We used adeno-associate virus (AAV2) for delivering neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) to the transplanted cells. If we used more than 1x107 capsides/ml AAV-BDNF for transfection, statistically significant photoreceptor protection was observed in the AAV-BDNF-IPE transplantation from phototoxicity. However, the rescue effect was not dose-dependent. Then, we examined the BDNF receptor TrkB expression, because the receptor may control the effect of BDNF. So far many isoforms of TrkB have reported and we examined two of the major isoforms of TrkB ; TrkB-FL which has tyrosine kinase activity in the cell and TrkB-T1 which has not. These isoforms showed not always completely same expression by immunohistochemistry. TrkB-FL was expressed mainly on nerve fiber layer, ganglion cells layer, and inner nuclear layer (INL), conversely TrkB-T1 was on INL and RPE. Both isoforms were not expressed in ONL and photoreceptor layer. From the results of double immunostaining with S100β, These isforms were expressed on Muller cells. Further these isoforms were expressed in the retina not only spatially but also temporally different way, although the expression was enhanced by the AAV-BDNF-IPE transplantation. When we performed in situ hybridization, same expression pattern were also confirmed. siRNA experiments showed significant less photoreceptor protection when we injected siRNA of TrkB-T1. When we examined differential gene expression by DNA microarray of Muller cell line, rMC-1 between BDNF stimulated and non-stimulated, neurotrophic factors that were so far reported were not many expressed. Another mechanism such as scavenging the ions in the surrounding circumstances may be important.
我们报道了一种安全的视网膜下虹膜色素上皮细胞移植术.当这些细胞被基因工程改造成表达神经营养因子时,移植拯救了感光细胞的光毒性。我们使用腺相关病毒(AAV 2)将神经营养因子,如脑源性神经营养因子(BDNF)输送到移植细胞。如果我们使用超过1 × 107个衣壳/ml AAV-BDNF进行转染,则在AAV-BDNF-IPE移植中观察到统计学显著的光感受器保护免受光毒性。然而,拯救作用不具有剂量依赖性。然后,我们检测了BDNF受体TrkB的表达,因为该受体可能控制BDNF的作用。到目前为止,已经报道了TrkB的许多同种型,并且我们检测了TrkB的两种主要同种型; TrkB-FL,其在细胞中具有酪氨酸激酶活性,而TrkB-T1则没有。免疫组化结果显示,这些亚型的表达并不总是完全相同。TrkB-FL主要表达于神经纤维层、神经节细胞层和内核层(INL),TrkB-T1主要表达于INL和RPE。这两种亚型在ONL和感光细胞层中均不表达。S100β免疫组化结果表明,这些异构体在Muller细胞上均有表达。此外,这些异构体在视网膜中的表达不仅在空间上而且在时间上不同,尽管AAV-BDNF-IPE移植增强了表达。当我们进行原位杂交时,同样的表达模式也得到了证实。当我们注射TrkB-T1的siRNA时,siRNA实验显示出显著更少的光感受器保护。当我们用DNA微阵列检测Muller细胞系rMC-1在BDNF刺激和未刺激之间的差异基因表达时,迄今报道的神经营养因子表达不多。另一种机制,如清除周围环境中的离子可能是重要的。
项目成果
期刊论文数量(64)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regeneration of the retina using pigment epithelial cell transplantation : A review.
使用色素上皮细胞移植进行视网膜再生:综述。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Wada Y;Abe T;et al.;Abe T.
- 通讯作者:Abe T.
Nipradilol inhibits apoptosis by preventing the activation of caspase-3 via S-nitrosylation and the cGMP-dependent pathway.
尼普地洛通过 S-亚硝基化和 cGMP 依赖性途径阻止 caspase-3 的激活,从而抑制细胞凋亡。
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Tomita H;Nakazawa T;Sugano E;Abe T;Tamai M.
- 通讯作者:Tamai M.
加齢黄斑変性とポリープ状脈絡膜血管症に対するトリアムシノロンテノン嚢下注射の短期的効果
曲安西龙Tenon囊下注射治疗年龄相关性黄斑变性和息肉状脉络膜血管病变的短期效果
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:涌沢亮介;吉田まどか;阿部俊明;吉田光;玉井信
- 通讯作者:玉井信
Protection of photoreceptor cells from phototoxicity by transplanted retinal pigment epithelial cells expressing different neurotrophic factors
- DOI:10.3727/000000005783982549
- 发表时间:2005-01-01
- 期刊:
- 影响因子:3.3
- 作者:Abe, T;Saigo, Y;Tamai, M
- 通讯作者:Tamai, M
Hypothermia protects cultured human retinal pigment epithelial cells against trypan blue toxicity
低温保护培养的人视网膜色素上皮细胞免受台盼蓝毒性
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Uchino E;Sonoda S;Nakao K;Sakamoto T;Kunikata H;Kunikata H;Kunikata H
- 通讯作者:Kunikata H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ABE Toshiaki其他文献
ABE Toshiaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ABE Toshiaki', 18)}}的其他基金
Intervention of retinal diseases using energy metabolism reprogramming
利用能量代谢重编程干预视网膜疾病
- 批准号:
20K21642 - 财政年份:2020
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of devices for retinal protection
视网膜保护装置的开发
- 批准号:
21592214 - 财政年份:2009
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of the neovasucular membranes in patients with age-related macular degeneration
年龄相关性黄斑变性患者新生血管膜的研究
- 批准号:
12671694 - 财政年份:2000
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Transplantation study against ischemic retinal disease
缺血性视网膜疾病的移植研究
- 批准号:
10671630 - 财政年份:1998
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Examination of phosducin gene
磷酸蛋白基因检查
- 批准号:
08672004 - 财政年份:1996
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Human cytomegalovirus infection and anti-receptor antibody
人巨细胞病毒感染与抗受体抗体
- 批准号:
05670700 - 财政年份:1993
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Autologe Translokation von Irispigmentepithel auf resorbierbaren Unterlagen als neue therapeutische Methode bei altersbedingter Makuladegeneration (Autologous iris pigment epithelium (IPE) translocation on biodegradable supports as new therapeutic modalit
可生物降解支架上的自体虹膜色素上皮(IPE)易位作为新的治疗方式
- 批准号:
5309240 - 财政年份:2001
- 资助金额:
$ 8.58万 - 项目类别:
Priority Programmes
Autologe Translokation von Irispigmentepithel auf resorbierbaren Unterlagen als neue therapeutische Methode bei altersbedingter Makuladegeneration (Autologous iris pigment epithelium (IPE) translocation on biodegradable supports as new therapeutic modalit
可生物降解支架上的自体虹膜色素上皮(IPE)易位作为新的治疗方式
- 批准号:
5309252 - 财政年份:2001
- 资助金额:
$ 8.58万 - 项目类别:
Priority Programmes
Autologe Translokation von Irispigmentepithel auf resorbierbaren Unterlagen als neue therapeutische Methode bei altersbedingter Makuladegeneration (Autologous iris pigment epithelium (IPE) translocation on biodegradable supports as new therapeutic modalit
可生物降解支架上的自体虹膜色素上皮(IPE)易位作为新的治疗方式
- 批准号:
5309246 - 财政年份:2001
- 资助金额:
$ 8.58万 - 项目类别:
Priority Programmes